Recent advances in the treatment of gynecologic cancers are promising, and education is needed to ensure that both oncology and primary care clinicians, including OB/GYNs, have a thorough knowledge of biomarkers, current and emerging therapies, and how the latest clinical trial data translates to real-world practice. In addition to immune checkpoint inhibitor therapies, other emerging therapies for endometrial cancer (EC) are generating promising data, including novel immunotherapies, HER2 inhibitors, and bispecific antibodies. Members of the multidisciplinary care team who care for patients with EC need to know about emerging therapies that are poised to change practice patterns. In the second activity of this CME Outfitters podcast series on gynecologic cancers, Drs. Richard Penson and Matthew Powell will present and discuss the very latest research on emerging treatment options for EC.
- Provider:CME Outfitters, LLC
- Activity Link: https://www.cmeoutfitters.com/activity/confusion-on-the-horizon-novel-therapies-emerging-for-the-treatment-of-endometrial-cancer/
- Start Date: 2024-09-30 05:00:00
- End Date: 2024-09-30 05:00:00
- Credit Details: IPCE Credits: 0.5 hours
AAPA Category 1 Credit™️: 0.5 hours
AMA PRA Category 1 Credit™️: 0.5 hours
Nursing: 0.5 hours
Pharmacy: 0.5 hours - MOC Credit Details: ABIM - 0.5 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: AstraZeneca (Any division) - Amount: 0 - Is Kind Support: False Source: Merck (Any division) - Amount: 0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Internal Medicine, Medical Oncology